Conventional cultures of established tumor cell lines
|
Relative low cost |
Limited 3D interaction |
|
Low care to culture |
Limited cell to cell interaction |
|
Low expertise to culture |
Limited cell to matrix interaction |
|
Easy genetic modification |
Limited microenvironment and intercellular communication |
|
Fast growth |
Limited or lack of cellular polarization |
|
Minimal culture requirement |
Genotypic and phenotypic selection of clones after several splitting |
|
Easy drug testing |
Inter and intra laboratories culture selection |
|
Easy/scalable experimental replicates |
Needs frequent authentication |
|
Easy co-culture experiments with immune cells |
|
Patient-derived tumor cell suspension
|
Representative of the original tumor immediately after isolation |
Difficult genetic stabilization (heterogeneity) |
|
Ideal for TME and single cell studies |
Difficult to culture |
|
|
Derived cell lines only partly representing the original tumor |
|
|
Low number of cells for functional experiments |
Cell lines-derived or patient-derived spheroids
|
Several plasticware tools to get spheroids from single cells |
Relative higher cost compared to conventional cultures |
|
Increment of cell to cell and cell to matrix interactions |
Difficulties in getting heterotypic spheroids |
|
Easier growth quantification compared to organoids |
Reduced architectural microenvironment |
|
Limited culture needs |
Difficulties in getting spheroids |
|
Cultured in well-defined media without serum |
Difficulties in setting functional assays |
|
|
Difficult experimental standardization |
|
|
Need of advanced microscopy equipment for analysis |
Patient-derived organoids
|
Partial preservation of cellular interactions and partial polarization |
Reciprocal cell interaction and gradient of factors are not always polarized as in vivo |
|
Genetically engineered |
Medium-high care to culture |
|
Identification of different cell types in the same organoid |
High culture cost |
|
Cultured in well-defined media |
Reduced architectural microenvironment |
|
Partial maintenance of genetic features and heterogeneity |
Interaction with stromal components not like in vivo and difficult to set in standard organoid medium |
|
Culture with self-immune cells |
Difficulties in setting functional experiments |
|
|
Low-medium frequency of efficient generation from patient |
|
|
Difficulties in standardization |
|
|
Needs of advanced microscopy equipment for analysis |
Animal models
|
Genetically determined |
High cost and strong specific skill |
|
Patient derived xenografts improve study of drug efficacy |
Not necessary mirror human cell physiology |
|
Humanized-mice partly resemble in vivo physiology |
The stromal components derive from the animal model |
|
|
Difficulties to study immune cell interactions |
Cultures in artificial scaffolds and organ on chip, associated with fluidic systems
|
Replaces animal models or reduces the number of animals used |
High cost and specific expertise requested |
|
Resembles more physiological conditions |
Difficult to standardize |
|
|
Needs new approaches to assess functional activity |